Santen Pharmaceutical Co Ltd
TSE:4536
Santen Pharmaceutical Co Ltd
TSE:4536
Price:
1 598 JPY
-0.34%
Market Closed
Updated:
May 17, 2024
Balance Sheet
Balance Sheet Decomposition
Santen Pharmaceutical Co Ltd
Santen Pharmaceutical Co Ltd
| Current Assets | 236.1B |
| Cash & Short-Term Investments | 95B |
| Receivables | 90.5B |
| Other Current Assets | 50.6B |
| Non-Current Assets | 199.6B |
| Long-Term Investments | 24.4B |
| PP&E | 71.6B |
| Intangibles | 83.8B |
| Other Non-Current Assets | 19.8B |
| Current Liabilities | 92.8B |
| Accounts Payable | 43.5B |
| Other Current Liabilities | 49.3B |
| Non-Current Liabilities | 36.8B |
| Long-Term Debt | 32.4B |
| Other Non-Current Liabilities | 4.4B |
Balance Sheet
Santen Pharmaceutical Co Ltd
Santen Pharmaceutical Co Ltd
Currency: JPY
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
65 945
|
99 818
|
53 297
|
69 283
|
70 796
|
91 430
|
62 888
|
83 014
|
57 903
|
94 582
|
|
| Cash Equivalents |
65 945
|
99 818
|
53 297
|
69 283
|
70 796
|
91 430
|
62 888
|
83 014
|
57 903
|
94 582
|
|
| Short-Term Investments |
187
|
234
|
333
|
472
|
267
|
452
|
527
|
1 293
|
774
|
379
|
|
| Total Receivables |
61 701
|
65 998
|
70 970
|
78 654
|
84 618
|
86 999
|
95 992
|
99 591
|
107 225
|
90 539
|
|
| Accounts Receivables |
59 607
|
63 950
|
68 799
|
76 115
|
81 957
|
84 224
|
93 028
|
95 992
|
103 608
|
90 539
|
|
| Other Receivables |
2 094
|
2 048
|
2 171
|
2 539
|
2 661
|
2 775
|
2 964
|
3 599
|
3 617
|
0
|
|
| Inventory |
20 133
|
24 996
|
28 502
|
30 636
|
35 235
|
35 282
|
41 575
|
37 141
|
39 352
|
43 185
|
|
| Other Current Assets |
2 706
|
3 693
|
3 909
|
4 322
|
3 826
|
4 393
|
5 249
|
8 387
|
8 072
|
7 454
|
|
| Total Current Assets |
150 672
|
194 739
|
157 011
|
183 367
|
194 742
|
218 556
|
206 231
|
229 426
|
213 326
|
236 139
|
|
| PP&E Net |
29 104
|
27 991
|
28 550
|
29 706
|
31 699
|
35 601
|
39 489
|
56 287
|
66 173
|
71 576
|
|
| PP&E Gross |
29 104
|
27 991
|
28 550
|
29 706
|
31 699
|
35 601
|
39 489
|
56 287
|
66 173
|
0
|
|
| Accumulated Depreciation |
0
|
55 704
|
57 059
|
60 025
|
53 706
|
56 212
|
60 938
|
64 530
|
68 613
|
0
|
|
| Intangible Assets |
77 855
|
77 241
|
116 165
|
112 200
|
108 397
|
97 723
|
103 104
|
116 502
|
88 924
|
83 819
|
|
| Goodwill |
0
|
6 440
|
22 770
|
22 295
|
22 713
|
22 127
|
12 704
|
13 715
|
7 385
|
0
|
|
| Long-Term Investments |
34 725
|
44 535
|
29 889
|
35 775
|
30 044
|
30 848
|
37 065
|
36 238
|
37 359
|
24 406
|
|
| Other Long-Term Assets |
5 266
|
4 453
|
4 521
|
5 120
|
3 591
|
3 913
|
6 692
|
7 808
|
8 012
|
19 759
|
|
| Other Assets |
0
|
6 440
|
22 770
|
22 295
|
22 713
|
22 127
|
12 704
|
13 715
|
7 385
|
0
|
|
| Total Assets |
304 200
N/A
|
355 399
+17%
|
358 906
+1%
|
388 463
+8%
|
391 186
+1%
|
408 768
+4%
|
405 285
-1%
|
459 976
+13%
|
421 179
-8%
|
435 699
+3%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
14 330
|
17 225
|
17 883
|
22 471
|
29 822
|
22 766
|
24 258
|
24 420
|
25 282
|
43 531
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
9 540
|
9 331
|
4 098
|
500
|
5 726
|
2 912
|
13 965
|
3 056
|
25 711
|
|
| Other Current Liabilities |
30 200
|
46 465
|
26 267
|
35 632
|
30 341
|
39 105
|
51 379
|
57 436
|
61 166
|
23 554
|
|
| Total Current Liabilities |
56 340
|
73 230
|
53 481
|
62 201
|
60 663
|
67 597
|
78 549
|
95 821
|
89 504
|
92 796
|
|
| Long-Term Debt |
25 351
|
12 944
|
7 619
|
3 500
|
3 563
|
6 602
|
7 234
|
18 967
|
33 151
|
32 439
|
|
| Deferred Income Tax |
2 874
|
3 988
|
17 963
|
12 909
|
9 389
|
7 228
|
3 626
|
2 526
|
1 592
|
1 377
|
|
| Minority Interest |
0
|
0
|
819
|
1 734
|
1 672
|
305
|
535
|
645
|
683
|
685
|
|
| Other Liabilities |
7 856
|
5 228
|
23 914
|
22 296
|
24 999
|
24 781
|
6 230
|
5 818
|
3 635
|
3 718
|
|
| Total Liabilities |
92 421
N/A
|
95 390
+3%
|
103 796
+9%
|
102 640
-1%
|
100 286
-2%
|
105 903
+6%
|
95 104
-10%
|
122 487
+29%
|
127 199
+4%
|
129 645
+2%
|
|
| Equity | |||||||||||
| Common Stock |
7 383
|
7 695
|
7 792
|
8 032
|
8 252
|
8 366
|
8 525
|
8 672
|
8 702
|
8 777
|
|
| Retained Earnings |
179 393
|
222 661
|
224 108
|
250 200
|
259 461
|
274 108
|
273 756
|
290 861
|
238 402
|
240 029
|
|
| Additional Paid In Capital |
8 077
|
8 389
|
8 417
|
8 657
|
8 661
|
8 746
|
8 954
|
9 370
|
9 789
|
9 854
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
9 470
|
14 364
|
10 230
|
11 150
|
11 075
|
8 438
|
7 917
|
0
|
|
| Treasury Stock |
18
|
0
|
10
|
11
|
1 131
|
1 033
|
934
|
718
|
364
|
1 018
|
|
| Other Equity |
16 944
|
2 612
|
5 333
|
4 581
|
5 427
|
1 528
|
8 805
|
20 866
|
29 534
|
48 412
|
|
| Total Equity |
211 779
N/A
|
260 009
+23%
|
255 110
-2%
|
285 823
+12%
|
290 900
+2%
|
302 865
+4%
|
310 181
+2%
|
337 489
+9%
|
293 980
-13%
|
306 054
+4%
|
|
| Total Liabilities & Equity |
304 200
N/A
|
355 399
+17%
|
358 906
+1%
|
388 463
+8%
|
391 186
+1%
|
408 768
+4%
|
405 285
-1%
|
459 976
+13%
|
421 179
-8%
|
435 699
+3%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
413
|
414
|
406
|
407
|
399
|
399
|
400
|
400
|
376
|
363
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
